Cargando…
mTOR kinase is a therapeutic target for respiratory syncytial virus and coronaviruses
Therapeutic interventions targeting viral infections remain a significant challenge for both the medical and scientific communities. While specific antiviral agents have shown success as therapeutics, viral resistance inevitably develops, making many of these approaches ineffective. This inescapable...
Autores principales: | Huynh, HoangDinh, Levitz, Ruth, Huang, Rong, Kahn, Jeffrey S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709853/ https://www.ncbi.nlm.nih.gov/pubmed/34952911 http://dx.doi.org/10.1038/s41598-021-03814-7 |
Ejemplares similares
-
mTORC1 impedes osteoclast differentiation via calcineurin and NFATc1
por: Huynh, HoangDinh, et al.
Publicado: (2018) -
Distinct patterns of innate immune activation by clinical isolates of respiratory syncytial virus
por: Levitz, Ruth, et al.
Publicado: (2017) -
mTOR Signaling Cascade in Psoriatic Disease: Double Kinase mTOR Inhibitor a Novel Therapeutic Target
por: Raychaudhuri, Smriti K, et al.
Publicado: (2014) -
Digital plasmonic nanobubble detection for rapid and ultrasensitive virus diagnostics
por: Liu, Yaning, et al.
Publicado: (2022) -
Induction of IL-6 and CCL5 (RANTES) in human respiratory epithelial (A549) cells by clinical isolates of respiratory syncytial virus is strain specific
por: Levitz, Ruth, et al.
Publicado: (2012)